lentinan has been researched along with deoxycytidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, M; Wu, B; Xie, Q; Zhan, Y; Zhao, W | 1 |
| Hou, J; Jin, W; Yang, Q; Yi, W; Yoo, S; Zhang, P | 1 |
1 review(s) available for lentinan and deoxycytidine
| Article | Year |
|---|---|
Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Gemcitabine; Humans; Lentinan; Urinary Bladder Neoplasms; Urothelium | 2015 |
1 other study(ies) available for lentinan and deoxycytidine
| Article | Year |
|---|---|
A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Delivery Systems; Female; Gemcitabine; Humans; Laser Therapy; Lasers; Lentinan; MCF-7 Cells; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanotubes, Carbon; Neoplasms, Experimental; Phototherapy; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermogravimetry; Xenograft Model Antitumor Assays | 2018 |